Serological comparison of systemic lupus erythematosus with neuropsychiatric lupus using synthetic nucleic acid antigens

Jia, 2019, Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus, Lupus, 28, 1128, 10.1177/0961203319861677 Hanly, 2019, Review: nervous system disease in systemic lupus erythematosus: current status and future directions, Arthritis Rheum., 71, 33, 10.1002/art.40591 Duarte-Delgado, 2019, Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus, Autoimmun. Rev., 18, 426, 10.1016/j.autrev.2018.12.004 Marín, 2019, Antibodies associated with neuropsychiatric lupus: pathophysiological role, prevalence and diagnostic usefulness, Rev. Colomb. Reumatol., 26, 111 Hermosillo-Romo, 2002, Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE), Best Pract. Res. Clin. Rheumatol., 16, 229, 10.1053/berh.2001.0223 Hanly, 2014, Diagnosis and management of neuropsychiatric SLE, Nat. Rev. Rheumatol., 10, 338, 10.1038/nrrheum.2014.15 Perez, 2017, Primary psychiatric disorder masking the diagnosis of neuropsychiatric lupus in a patient with altered mental status: a case report, Cureus, 9 Sinclair, 2015, Immunological mechanisms of neuropsychiatric lupus, Curr. Immunol. Rev., 11, 93, 10.2174/1573395511666150707181943 Lefranc, 2007, Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach, Arthritis Rheum., 56, 3420, 10.1002/art.22863 Hirohata, 2018, Pathology of neuropsychiatrie systemic lupus erythematosus, 43 Pisetsky, 2016, Anti-DNA antibodies - quintessential biomarkers of SLE, Nat. Rev. Rheumatol., 12, 102, 10.1038/nrrheum.2015.151 Kimura, 2010, Antibodies in patients with neuropsychiatric systemic lupus erythematosus, Neurology, 74, 1372, 10.1212/WNL.0b013e3181dad590 Teodorescu, 2002, Clinical value of anti-ssDNA (denatured DNA) autoantibody test: beauty is in the eyes of the beholder, Clin. Appl. Immunol. Rev., 2, 115, 10.1016/S1529-1049(01)00042-3 M, 2010, Pathogenic and epiphenomenal anti-DNA antibodies in SLE, Autoimmune Dis., 2011 Rodkey, 2000, DNA hydrolysis by monoclonal autoantibody BV 04-01, Appl. Biochem. Biotechnol. Part A Enzyme Eng. Biotechnol., 83, 95, 10.1385/ABAB:83:1-3:95 Hirohata, 2014, Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus, Arthritis Res. Ther., 16, 450, 10.1186/s13075-014-0450-z Samuelsen, 2020, Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens, P L o S One, 13 Khatri, 2020, Combined assay for detecting autoantibodies to nucleic acids and apolipoprotein H in patients with systemic lupus erythematosus, 57, 10.1007/978-1-0716-0138-9_6 Bonat, 2016, Multivariate covariance generalized linear models, J. R. Stat. Soc. Ser. C (Applied Stat., 65, 649, 10.1111/rssc.12145 2019 Bonat, 2018, Multiple response variables regression models in R: the mcglm package, J. Stat. Software, 84, 1 Klecka, 2018, Autoantibody profiling in lupus patients using synthetic nucleic acids, Sci. Rep., 8, 5554, 10.1038/s41598-018-23910-5 Junager, 2015, Revealing nucleic acid mutations using Förster resonance energy transfer-based probes, Sensors, 16, 1173, 10.3390/s16081173 Kumar, 2014, Rapid genotyping using pyrene− perylene locked nucleic acid complexes, Artif. DNA PNA XNA, 4, 58, 10.4161/adna.25903 Taskova, 2013, Synthetic nucleic acid analogues in gene therapy: an update for peptide–oligonucleotide conjugates, Chembiochem, 18, 1671, 10.1002/cbic.201700229 Besselink, 2002, Sephadex-based cell-affinity adsorbents: preparation and performance, Biotechnol. Appl. Biochem., 35, 55, 10.1042/BA20010062 Healthcare, 2002 Kruger, 1994, The Bradford method for protein quantitation, Methods Mol. Biol., 32, 9 Kummitha, 2012, HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions, J. Immunol. Methods, 384, 43, 10.1016/j.jim.2012.07.003 Van Der Meulen, 2017, Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus, Rheumatology, 56, 1407, 10.1093/rheumatology/kex073 Pradhan, 2015, Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India, Rheumatol. Int., 35, 541, 10.1007/s00296-014-3114-z Conti, 2004, Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies, Arthritis Res. Ther., 6, R366, 10.1186/ar1198 Hu, 2015, Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus, PloS One, 10, 126643 Jiang, 2019, Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus, Arthritis Res. Ther., 21, 189, 10.1186/s13075-019-1971-2 Langer-Gould, 2017, Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study, Neurology, 89, 1330, 10.1212/WNL.0000000000004412